Tailoring Lipid Nanoparticle with Ex Situ Incorporated Conjugated Oligoelectrolyte for Enhanced mRNA Delivery Efficiency
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202405048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Wilson Wee Mia Soh und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Lipids. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National University of Singapore, Singapore MOE Tier 2.
Abstract (Originalsprache)
Developing new lipid nanoparticle (LNP) formulations typically involves reconstruction from separate elements followed by rigorous purification steps, contributing to drawn‐out drug discovery processes. Membrane‐intercalating conjugated oligoelectrolytes (COEs) are water‐soluble molecules featuring a conjugated backbone and peripheral ionic groups, specifically designed to spontaneously integrate into lipid bilayers. Herein, an ex situ strategy to “dope” the representative COE‐S6 into pre‐formed messenger RNA‐LNPs (mRNA‐LNPs) is presented, exploiting its spontaneous membrane intercalation property through a straightforward add‐and‐mix procedure. Incorporating 0.2% COE‐S6 into mRNA‐LNPs relative to lipid content reduced particle size from 84.5 ± 1 to 67.9 ± 0.8 nm, elevated cellular uptake, and improved endosomal escape. These traits culminate in an increase in in cellula transfection from 24.2 ± 1.6% to 98.7 ± 0.6%. When injected intravenously into healthy BALB/c mice, the optimized COE‐S6‐doped mRNA‐LNPs boost in vivo luciferase expression by 1.75‐fold. Additionally, COE‐S6‐doped mRNA‐LNPs exhibit fluorogenic properties, enabling intracellular mechanistic studies via confocal microscopy. This simple method enhances the properties of mRNA‐LNPs with minimal COE quantities, offering a novel strategy to improve existing LNP formulations and provide optical reporting capabilities, essential for expediting drug discovery and delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, National University of Singapore, Singapore, 117543, Singapore.
- Institute for Functional Intelligent Materials, National University of Singapore, Singapore, 117544, Singapore.
- Program in Emerging Infectious Diseases, Duke-NUS Medical School, National University of Singapore, Singapore, 169857, Singapore.
- Viral Research and Experimental Medicine Centre, SingHealth Duke-NUS Academic Medical Centre, Singapore, 169857, Singapore.
ORCID-Profile: Wilson Wee Mia Soh, Guillermo C Bazan
Förderung
- National University of Singapore
- Singapore MOE Tier 2
Zitieren
APA
Soh, W. W. M., Finol, E., Chan, S. J. W., Zhu, J. Y., Liau, S. S. J. K., Bier, A., Ooi, E. E., & Bazan, G. C. (2025). Tailoring Lipid Nanoparticle with Ex Situ Incorporated Conjugated Oligoelectrolyte for Enhanced mRNA Delivery Efficiency. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405048
Vancouver
Soh WWM, Finol E, Chan SJW, Zhu JY, Liau SSJK, Bier A, et al. Tailoring Lipid Nanoparticle with Ex Situ Incorporated Conjugated Oligoelectrolyte for Enhanced mRNA Delivery Efficiency. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405048
BibTeX
@article{Soh2025,
author = {Soh, Wilson Wee Mia and Finol, Esteban and Chan, Samuel J W and Zhu, Ji-Yu and Liau, Sebastian Sean Jing Kang and Bier, Ava and Ooi, Eng Eong and Bazan, Guillermo C},
title = {Tailoring Lipid Nanoparticle with Ex Situ Incorporated Conjugated Oligoelectrolyte for Enhanced mRNA Delivery Efficiency},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202405048}
}
EUVIMED